Porphyrias
- PMID: 20226990
- DOI: 10.1016/S0140-6736(09)61925-5
Porphyrias
Abstract
Hereditary porphyrias are a group of eight metabolic disorders of the haem biosynthesis pathway that are characterised by acute neurovisceral symptoms, skin lesions, or both. Every porphyria is caused by abnormal function of a separate enzymatic step, resulting in a specific accumulation of haem precursors. Seven porphyrias are the result of a partial enzyme deficiency, and a gain of function mechanism has been characterised in a new porphyria. Acute porphyrias present with acute attacks, typically consisting of severe abdominal pain, nausea, constipation, confusion, and seizure, and can be life-threatening. Cutaneous porphyrias present with either acute painful photosensitivity or skin fragility and blisters. Rare recessive porphyrias usually manifest in early childhood with either severe cutaneous photosensitivity and chronic haemolysis or chronic neurological symptoms with or without photosensitivity. Porphyrias are still underdiagnosed, but when they are suspected, and dependent on clinical presentation, simple first-line tests can be used to establish the diagnosis in all symptomatic patients. Diagnosis is essential to enable specific treatments to be started as soon as possible. Screening of families to identify presymptomatic carriers is crucial to decrease risk of overt disease of acute porphyrias through counselling about avoidance of potential precipitants.
Copyright 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
[Porphyrias and haem related disorders].Rev Med Interne. 2016 Mar;37(3):173-85. doi: 10.1016/j.revmed.2015.12.005. Epub 2016 Jan 7. Rev Med Interne. 2016. PMID: 26774916 Review. French.
-
[Hereditary porphyrias and heme related disorders].Bull Acad Natl Med. 2014 Jun;198(6):1069-93. Bull Acad Natl Med. 2014. PMID: 26983187 French.
-
Porphyrias: A 2015 update.Clin Res Hepatol Gastroenterol. 2015 Sep;39(4):412-25. doi: 10.1016/j.clinre.2015.05.009. Epub 2015 Jul 2. Clin Res Hepatol Gastroenterol. 2015. PMID: 26142871 Review.
-
Management of acute and cutaneous porphyrias.Int J Clin Pract. 2002 May;56(4):272-8. Int J Clin Pract. 2002. PMID: 12074210 Review.
-
Neurological Manifestations of Acute Porphyrias.Curr Neurol Neurosci Rep. 2022 Jul;22(7):355-362. doi: 10.1007/s11910-022-01205-7. Epub 2022 Jun 4. Curr Neurol Neurosci Rep. 2022. PMID: 35665475 Review.
Cited by
-
Acute Intermittent Porphyria: A Diagnostic Conundrum.Cureus. 2024 Oct 26;16(10):e72419. doi: 10.7759/cureus.72419. eCollection 2024 Oct. Cureus. 2024. PMID: 39463915 Free PMC article.
-
CRISPR/Cas9-Mediated fech Knockout Zebrafish: Unraveling the Pathogenesis of Erythropoietic Protoporphyria and Facilitating Drug Screening.Int J Mol Sci. 2024 Oct 8;25(19):10819. doi: 10.3390/ijms251910819. Int J Mol Sci. 2024. PMID: 39409147 Free PMC article.
-
Human Chorionic Gonadotropin (hCG) Injections Exacerbating Acute Intermittent Porphyria in a 34-Year-Old Woman.Cureus. 2024 Sep 4;16(9):e68651. doi: 10.7759/cureus.68651. eCollection 2024 Sep. Cureus. 2024. PMID: 39371821 Free PMC article.
-
Palliative Care Aspects of Acute Intermittent Porphyria - A Case Report.Indian J Palliat Care. 2024 Jul-Sep;30(3):275-278. doi: 10.25259/IJPC_14_2024. Epub 2024 Aug 23. Indian J Palliat Care. 2024. PMID: 39371493 Free PMC article.
-
Long-term follow-up of givosiran treatment in patients with acute intermittent porphyria from a phase 1/2, 48-month open-label extension study.Orphanet J Rare Dis. 2024 Oct 3;19(1):365. doi: 10.1186/s13023-024-03284-w. Orphanet J Rare Dis. 2024. PMID: 39363243 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
